Epithelial-mesenchymal transition contributes to pulmonary fibrosis via aberrant epithelial/fibroblastic cross-talk
Epithelial-mesenchymal transition contributes to pulmonary fibrosis via aberrant epithelial/fibroblastic cross-talk
Idiopathic pulmonary fibrosis (IPF) is the prototypic progressive fibrotic interstitial lung disease. Median survival is only 3 years, and treatment options are limited. IPF is thought to be a result of a combination of genetic and environmental factors with repetitive micro-injuries to alveolar epithelial cells playing a central role. IPF is characterised by aberrant extra cellular matrix (ECM) deposition by activated myofibroblasts. Epithelial-mesenchymal transition (EMT) is a process where polarised
epithelial cells undergo molecular changes allowing them to gain a mesenchymal phenotype, with a subsequent enhanced ability to produce ECM components and increased migration and/or invasion. The source of myofibroblasts in IPF has been debated for many years, and EMT has been proposed as a source of these cells. However, lineage tracing in transgenic mice suggests the contribution of epithelial cells, which have undergone EMT, to the fibroblast population may be negligible. Instead, recent findings suggest that alveolar epithelial type II (ATII) cells undergoing EMT promote a profibrotic microenvironment through paracrine signalling activating local fibroblasts. This review paper explores the contribution of ATII cells, which have undergone EMT, in the context of pulmonary
fibrosis.
31-35
Hill, Charlotte
6d1cfed3-11b1-48af-b171-b8726ab673eb
Jones, Mark
a6fd492e-058e-4e84-a486-34c6035429c1
Davies, Donna
7de8fdc7-3640-4e3a-aa91-d0e03f990c38
Wang, Yihua
f5044a95-60a7-42d2-87d6-5f1f789e3a7e
April 2019
Hill, Charlotte
6d1cfed3-11b1-48af-b171-b8726ab673eb
Jones, Mark
a6fd492e-058e-4e84-a486-34c6035429c1
Davies, Donna
7de8fdc7-3640-4e3a-aa91-d0e03f990c38
Wang, Yihua
f5044a95-60a7-42d2-87d6-5f1f789e3a7e
Hill, Charlotte, Jones, Mark, Davies, Donna and Wang, Yihua
(2019)
Epithelial-mesenchymal transition contributes to pulmonary fibrosis via aberrant epithelial/fibroblastic cross-talk.
Journal of Lung Health and Diseases, 3 (2), .
Abstract
Idiopathic pulmonary fibrosis (IPF) is the prototypic progressive fibrotic interstitial lung disease. Median survival is only 3 years, and treatment options are limited. IPF is thought to be a result of a combination of genetic and environmental factors with repetitive micro-injuries to alveolar epithelial cells playing a central role. IPF is characterised by aberrant extra cellular matrix (ECM) deposition by activated myofibroblasts. Epithelial-mesenchymal transition (EMT) is a process where polarised
epithelial cells undergo molecular changes allowing them to gain a mesenchymal phenotype, with a subsequent enhanced ability to produce ECM components and increased migration and/or invasion. The source of myofibroblasts in IPF has been debated for many years, and EMT has been proposed as a source of these cells. However, lineage tracing in transgenic mice suggests the contribution of epithelial cells, which have undergone EMT, to the fibroblast population may be negligible. Instead, recent findings suggest that alveolar epithelial type II (ATII) cells undergoing EMT promote a profibrotic microenvironment through paracrine signalling activating local fibroblasts. This review paper explores the contribution of ATII cells, which have undergone EMT, in the context of pulmonary
fibrosis.
Text
Epithelial-mesenchymal transition contributes to pulmonary fibrosis via aberrant epithelial-fibroblastic cross-talk
- Accepted Manuscript
More information
Accepted/In Press date: 3 April 2019
Published date: April 2019
Identifiers
Local EPrints ID: 429970
URI: http://eprints.soton.ac.uk/id/eprint/429970
PURE UUID: 1e72f299-2324-400f-85ba-4ca4f801f894
Catalogue record
Date deposited: 09 Apr 2019 16:30
Last modified: 16 Mar 2024 07:44
Export record
Contributors
Author:
Charlotte Hill
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics